BCL2i CLAG-M in R/R Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Sallman, MD
Moffitt Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Moffitt Cancer Center
Tampa, Florida, United States
Alison Walker, MDDavid Sallman, MDEric Padron, MDJeffrey Lancet, MDOnyee Chan, MDRami Komrokji, MDSeongseok Yun, MD, PhDTimothy Kubal, MDZoey Xie, MDRecruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Jacqueline Garcia, MDNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Nov 2024
- Primary completion
- 30 Nov 2027
- Completion
- 30 Nov 2027
- Last update posted
- 1 Apr 2026
- Registered enrollment
- 52
- Registry id
- NCT06660368
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.